Exercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and Progression.

Pharmacologic manipulation of the immune system is emerging as a viable and robust treatment for some cancer patients. Exercise-induced modulation of the immune system may be another adjunctive strategy for inhibiting tumor initiation and progression. In healthy individuals, exercise has been shown to modulate a number of cell subsets involved in innate and adaptive immunity. Here, we provide an overview of the current state of knowledge pertaining to exercise modulation of the inflammation-immune axis in cancer. The current evidence suggests that exercise may be a promising adjunctive strategy that can favorably alter numerous components of the immune system, which, in turn, may modulate tumorigenesis. However, many important knowledge gaps are evident. To this end, we propose a framework to guide future research efforts investigating the immune effects of exercise in cancer.

[1]  A. Alizadeh,et al.  Effects of exercise training together with tamoxifen in reducing mammary tumor burden in mice: Possible underlying pathway of miR-21. , 2015, European journal of pharmacology.

[2]  L. Jones Precision Oncology Framework for Investigation of Exercise As Treatment for Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  E. Garon Current Perspectives in Immunotherapy for Non-Small Cell Lung Cancer. , 2015, Seminars in oncology.

[4]  Xue Han,et al.  Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future. , 2015, The Journal of clinical investigation.

[5]  Ross Arena,et al.  Exercise and the cardiovascular system: clinical science and cardiovascular outcomes. , 2015, Circulation research.

[6]  R. Simpson,et al.  NK cells and exercise: implications for cancer immunotherapy and survivorship. , 2015, Discovery medicine.

[7]  P. Sharma,et al.  The future of immune checkpoint therapy , 2015, Science.

[8]  Gregory Palmer,et al.  Modulation of Murine Breast Tumor Vascularity, Hypoxia, and Chemotherapeutic Response by Exercise , 2015, Journal of the National Cancer Institute.

[9]  Jianxiang Zhao,et al.  Walk-run training improves the anti-inflammation properties of high-density lipoprotein in patients with metabolic syndrome. , 2015, The Journal of clinical endocrinology and metabolism.

[10]  K. Courneya,et al.  Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study , 2015, British Journal of Cancer.

[11]  J. Wolchok,et al.  Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma. , 2014, Cancer treatment reviews.

[12]  Molin Wang,et al.  Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  J. Steiner,et al.  Exercise effects on polyp burden and immune markers in the ApcMin/+ mouse model of intestinal tumorigenesis , 2014, International journal of oncology.

[14]  N. Mutrie,et al.  Effects of an exercise and hypocaloric healthy eating intervention on indices of psychological health status, hypothalamic-pituitary-adrenal axis regulation and immune function after early-stage breast cancer: a randomised controlled trial , 2014, Breast Cancer Research.

[15]  Deepak Mittal,et al.  New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape. , 2014, Current opinion in immunology.

[16]  S. Demaria,et al.  Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death , 2014, Oncoimmunology.

[17]  D. Abdalla,et al.  Innate immune response adaptation in mice subjected to administration of DMBA and physical activity , 2013, Oncology letters.

[18]  Jorming Goh,et al.  Exercise Training in Transgenic Mice Is Associated with Attenuation of Early Breast Cancer Growth in a Dose-Dependent Manner , 2013, PloS one.

[19]  Z. Trajanoski,et al.  Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. , 2013, Immunity.

[20]  S. Demaria,et al.  An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non–Small Cell Lung Cancer , 2013, Cancer Immunology Research.

[21]  H. Schreiber,et al.  Innate and adaptive immune cells in the tumor microenvironment , 2013, Nature Immunology.

[22]  R. Uslu,et al.  Effects of exercise on angiogenesis and apoptosis-related molecules, quality of life, fatigue and depression in breast cancer patients. , 2013, European journal of cancer care.

[23]  C. Hudis,et al.  Molecular Pathways: Adipose Inflammation as a Mediator of Obesity-Associated Cancer , 2013, Clinical Cancer Research.

[24]  M. Kalos,et al.  Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology. , 2013, Immunity.

[25]  L. Zitvogel,et al.  Molecular mechanisms of ATP secretion during immunogenic cell death , 2013, Cell Death and Differentiation.

[26]  Jason D. Allen,et al.  Modulation of Circulating Angiogenic Factors and Tumor Biology by Aerobic Training in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy , 2013, Cancer Prevention Research.

[27]  Antoni Ribas,et al.  Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. , 2013, The New England journal of medicine.

[28]  B. Pedersen Muscle as a secretory organ. , 2013, Comprehensive Physiology.

[29]  D. Abdalla,et al.  The influence of physical activity on the profile of immune response cells and cytokine synthesis in mice with experimental breast tumors induced by 7,12-dimethylbenzanthracene , 2013, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[30]  J. Davis,et al.  Effects of voluntary exercise on tumorigenesis in the C3(1)/SV40Tag transgenic mouse model of breast cancer. , 2013, International journal of oncology.

[31]  Laurence Zitvogel,et al.  Immunogenic cell death in cancer therapy. , 2013, Annual review of immunology.

[32]  M. Dewhirst,et al.  Effects and potential mechanisms of exercise training on cancer progression: A translational perspective , 2013, Brain, Behavior, and Immunity.

[33]  Valentin A. Pavlov,et al.  The vagus nerve and the inflammatory reflex—linking immunity and metabolism , 2012, Nature Reviews Endocrinology.

[34]  A. Conney,et al.  Inhibition of Progression of Androgen-Dependent Prostate LNCaP Tumors to Androgen Independence in SCID Mice by Oral Caffeine and Voluntary Exercise , 2012, Nutrition and cancer.

[35]  Y. Ma,et al.  Effect of exercise training intensity on murine T‐regulatory cells and vaccination response , 2012, Scandinavian journal of medicine & science in sports.

[36]  Rajesh C. Dash,et al.  Exercise modulation of the host-tumor interaction in an orthotopic model of murine prostate cancer. , 2012, Journal of applied physiology.

[37]  T. Golub,et al.  Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion , 2012, Nature.

[38]  R. Simpson,et al.  Exercise and the aging immune system , 2012, Ageing Research Reviews.

[39]  Rui-Ru Ji,et al.  An immune-active tumor microenvironment favors clinical response to ipilimumab , 2012, Cancer Immunology, Immunotherapy.

[40]  David C. Smith,et al.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.

[41]  Sameer M. Siddiqi,et al.  Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. , 2012, Journal of the National Cancer Institute.

[42]  T. Byers,et al.  Dietary supplements and cancer prevention: balancing potential benefits against proven harms. , 2012, Journal of the National Cancer Institute.

[43]  George Coukos,et al.  T-regulatory cells: key players in tumor immune escape and angiogenesis. , 2012, Cancer research.

[44]  R. deLeeuw,et al.  The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature , 2012, Clinical Cancer Research.

[45]  M. Febbraio,et al.  Muscles, exercise and obesity: skeletal muscle as a secretory organ , 2012, Nature Reviews Endocrinology.

[46]  Alison P. Klein,et al.  Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape , 2012, Science Translational Medicine.

[47]  G. Trinchieri Cancer and inflammation: an old intuition with rapidly evolving new concepts. , 2012, Annual review of immunology.

[48]  P. Goodwin,et al.  Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  G. Dranoff,et al.  Experimental mouse tumour models: what can be learnt about human cancer immunology? , 2011, Nature Reviews Immunology.

[50]  Jun Wang,et al.  Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma , 2011, Medical oncology.

[51]  B. Spiegelman,et al.  Molecular mechanisms of cancer development in obesity , 2011, Nature Reviews Cancer.

[52]  K. Murphy,et al.  Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells , 2011, The Journal of experimental medicine.

[53]  R. Schreiber,et al.  Type I interferon is selectively required by dendritic cells for immune rejection of tumors , 2011, The Journal of experimental medicine.

[54]  Martin R. Lindley,et al.  The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease , 2011, Nature Reviews Immunology.

[55]  Heidi Ledford Melanoma drug wins US approval , 2011, Nature.

[56]  R. Schreiber,et al.  Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.

[57]  R. Schreiber,et al.  Natural innate and adaptive immunity to cancer. , 2011, Annual review of immunology.

[58]  Yuan Qi,et al.  Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer. , 2011, Journal of the National Cancer Institute.

[59]  P. Carmeliet,et al.  HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. , 2011, Cancer cell.

[60]  Katsuhiko Suzuki,et al.  Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice. , 2010, Exercise immunology review.

[61]  N. Berger,et al.  Energy balance, host-related factors, and cancer progression. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  D. Schadendorf,et al.  Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.

[63]  R. Weinberg,et al.  Tumor-host interactions: a far-reaching relationship. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  K. Courneya,et al.  American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. , 2010, Medicine and science in sports and exercise.

[65]  L. Zitvogel,et al.  Chemotherapy and radiotherapy: cryptic anticancer vaccines. , 2010, Seminars in immunology.

[66]  Jeffrey W. Pollard,et al.  Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.

[67]  Alberto Mantovani,et al.  Macrophages, innate immunity and cancer: balance, tolerance, and diversity. , 2010, Current opinion in immunology.

[68]  Zlatko Trajanoski,et al.  Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. , 2010, Gastroenterology.

[69]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[70]  Steven J. M. Jones,et al.  Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. , 2010, The New England journal of medicine.

[71]  J. Pignon,et al.  Immunogenic death of colon cancer cells treated with oxaliplatin , 2010, Oncogene.

[72]  Zlatko Trajanoski,et al.  In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[73]  M. Joyner,et al.  Exercise protects the cardiovascular system: effects beyond traditional risk factors , 2009, The Journal of physiology.

[74]  E. McAuley,et al.  Cardiovascular Exercise Training Extends Influenza Vaccine Seroprotection in Sedentary Older Adults: The Immune Function Intervention Trial , 2009, Journal of the American Geriatrics Society.

[75]  N. Kawashima,et al.  Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody , 2009, Clinical Cancer Research.

[76]  D. Raulet,et al.  Oncogenic stress sensed by the immune system: role of natural killer cell receptors , 2009, Nature Reviews Immunology.

[77]  R. Newton,et al.  Australian Association for Exercise and Sport Science position stand: optimising cancer outcomes through exercise. , 2009, Journal of science and medicine in sport.

[78]  H. Boezen,et al.  Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer. , 2009, Gynecologic oncology.

[79]  U. Wisløff,et al.  Swim training suppresses tumor growth in mice. , 2009, Journal of applied physiology.

[80]  R. Ross,et al.  The future of obesity reduction: beyond weight loss , 2009, Nature Reviews Endocrinology.

[81]  B. Pence,et al.  Exercise training‐induced lowering of inflammatory (CD14+CD16+) monocytes: a role in the anti‐inflammatory influence of exercise? , 2008, Journal of leukocyte biology.

[82]  T. Kizaki,et al.  Adaptation of macrophages to exercise training improves innate immunity. , 2008, Biochemical and biophysical research communications.

[83]  R. Weinberg,et al.  Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin , 2008, Cell.

[84]  T. Lawrence,et al.  “Re-educating” tumor-associated macrophages by targeting NF-κB , 2008, The Journal of experimental medicine.

[85]  J. Fleming,et al.  Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice. , 2008, Cancer research.

[86]  M. Tsao,et al.  Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma. , 2008, The Journal of thoracic and cardiovascular surgery.

[87]  M. Schuler,et al.  An immune escape screen reveals Cdc42 as regulator of cancer susceptibility to lymphocyte-mediated tumor suppression. , 2008, Blood.

[88]  B. Seliger Different regulation of MHC Class I antigen processing components in human tumors , 2008, Journal of immunotoxicology.

[89]  M. Lotze,et al.  The grateful dead: damage‐associated molecular pattern molecules and reduction/oxidation regulate immunity , 2007, Immunological reviews.

[90]  Laurence Zitvogel,et al.  Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy , 2007, Nature Medicine.

[91]  Markus F Neurath,et al.  An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression , 2007, Nature Protocols.

[92]  A. Mantovani,et al.  Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft. , 2007, The Journal of investigative dermatology.

[93]  Katsunori Yoshida,et al.  Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor β signaling, promoting cirrhosis and hepatocellular carcinoma , 2007, Hepatology.

[94]  H. Liao,et al.  Modulation of Dendritic Cells by Endurance Training , 2007, International journal of sports medicine.

[95]  M. Bianchi,et al.  The secretion of HMGB1 is required for the migration of maturing dendritic cells , 2007, Journal of leukocyte biology.

[96]  Z. Trajanoski,et al.  Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.

[97]  H. Liao,et al.  Effect of a periodized exercise training and active recovery program on antitumor activity and development of dendritic cells. , 2006, The Journal of sports medicine and physical fitness.

[98]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[99]  L. Coussens,et al.  De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. , 2005, Cancer cell.

[100]  K. Courneya,et al.  Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors. , 2005, Journal of applied physiology.

[101]  S. Sheen-Chen,et al.  Serum Levels of Hepatocyte Growth Factor in Patients with Breast Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[102]  N. Kawashima,et al.  Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[103]  J. Woods,et al.  Exercise delays allogeneic tumor growth and reduces intratumoral inflammation and vascularization. , 2004, Journal of applied physiology.

[104]  R. Schreiber,et al.  The three Es of cancer immunoediting. , 2004, Annual review of immunology.

[105]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[106]  A. Steensberg,et al.  IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. , 2003, American journal of physiology. Endocrinology and metabolism.

[107]  W. Kraus,et al.  Effects of the amount and intensity of exercise on plasma lipoproteins. , 2002, The New England journal of medicine.

[108]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[109]  C. Yee,et al.  Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation , 2002, Nature.

[110]  Yoshimasa Tanaka,et al.  Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[111]  W. Kraemer,et al.  The relationship of natural killer cell counts, perforin mRNA and CD2 expression to post-exercise natural killer cell activity in humans. , 2002, Acta physiologica Scandinavica.

[112]  S. Mirbod,et al.  Immunomodulatory action of chronic exercise on macrophage and lymphocyte cytokine production in mice. , 2002, Acta physiologica Scandinavica.

[113]  Christophe Caux,et al.  Tumour escape from immune surveillance through dendritic cell inactivation. , 2002, Seminars in cancer biology.

[114]  R. Tampé,et al.  Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway. , 2001, Cancer research.

[115]  L. Lanier,et al.  Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[116]  R. Goldsmith,et al.  Exercise and autonomic function in health and cardiovascular disease. , 2001, Cardiology clinics.

[117]  O. Finn,et al.  Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. , 2001, Cancer research.

[118]  P. Schlag,et al.  Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. , 2001, Cancer research.

[119]  R. Schreiber,et al.  IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.

[120]  P. Musiani,et al.  The intriguing role of polymorphonuclear neutrophils in antitumor reactions. , 2001, Blood.

[121]  L. Bouillon,et al.  Effects of Endurance Training on Selected Parameters of Immune Function in Elderly Women , 2000, Gerontology.

[122]  M. Mittlböck,et al.  Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis. , 1999, Shock.

[123]  B. C. Wong,et al.  Helicobacter pylori infection and gastric cancer. , 1999, Hong Kong medical journal = Xianggang yi xue za zhi.

[124]  E. McAuley,et al.  Effects of 6 months of moderate aerobic exercise training on immune function in the elderly , 1999, Mechanisms of Ageing and Development.

[125]  Guo‐Jun Zhang,et al.  Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. , 1999, Anticancer Research.

[126]  J. Woods,et al.  Chronic exercise increases macrophage-mediated tumor cytolysis in young and old mice. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[127]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[128]  S. Sheen-Chen,et al.  Serum concentration of tumor necrosis factor in patients with breast cancer , 1997, Breast Cancer Research and Treatment.

[129]  J. Tschopp,et al.  Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape , 1996, Science.

[130]  D. Pyne,et al.  Effects of an intensive 12-wk training program by elite swimmers on neutrophil oxidative activity. , 1995, Medicine and science in sports and exercise.

[131]  Eero Pukkala,et al.  Cancer risk after renal transplantation in the nordic countries, 1964–1986 , 1995, International journal of cancer.

[132]  V. Hack,et al.  PMN cell counts and phagocytic activity of highly trained athletes depend on training period. , 1994, Journal of applied physiology.

[133]  A. Fauci,et al.  Corticosteroid‐Mediated Immunoregulation in Man , 1982, Immunological reviews.

[134]  T. Takken,et al.  Effects of exercise on immune function in patients with cancer: a systematic review. , 2013, Exercise immunology review.

[135]  G. Norata,et al.  Emerging role of high density lipoproteins as a player in the immune system. , 2012, Atherosclerosis.

[136]  Nutrition and physical activity guidelines for cancer survivors , 2012, CA: a cancer journal for clinicians.

[137]  Hinnak Northoff,et al.  Position statement. Part one: Immune function and exercise. , 2011, Exercise immunology review.

[138]  E. Lindeman,et al.  [Guideline "Cancer rehabilitation"]. , 2011, Nederlands tijdschrift voor geneeskunde.

[139]  F. Dhabhar,et al.  Position statement. Part two: Maintaining immune health. , 2011, Exercise immunology review.

[140]  L. Zitvogel,et al.  Calreticulin exposure dictates the immunogenicity of cancer cell death , 2007, Nature Medicine.

[141]  P. Tassone,et al.  HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells. , 2005, Blood.

[142]  S. Itzkowitz,et al.  Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[143]  J. Peake Exercise-induced alterations in neutrophil degranulation and respiratory burst activity: possible mechanisms of action. , 2002, Exercise immunology review.

[144]  M. Smyth,et al.  NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. , 2001, International immunology.

[145]  F. Marincola,et al.  Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. , 2000, Advances in immunology.

[146]  J. Turkson,et al.  Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. , 1999, Immunity.